Equity

BME

Health Sciences Trust

Overview

Loading

Performance

Performance

  • Returns

  1y 3y 5y 10y Incept. Performance data for certain classes of shares of certain funds are based on pre-class inception information dating back to an older class of fund shares. This information may be considered when assessing a fund's performance, but it does not represent actual performance of these classes of shares. The inception date noted under Key Fund Facts is the date the class of shares was incepted. See fund prospectus or fact sheet for details.
14.29 10.65 16.70 12.10 13.07
Market Price (%) Market price return represents changes to the fund’s closing market price on its primary exchange and accounts for distributions from the fund. 16.10 11.79 17.44 13.56 12.85
  YTD 1m 1y 3y 5y 10y Incept. Performance data for certain classes of shares of certain funds are based on pre-class inception information dating back to an older class of fund shares. This information may be considered when assessing a fund's performance, but it does not represent actual performance of these classes of shares. The inception date noted under Key Fund Facts is the date the class of shares was incepted. See fund prospectus or fact sheet for details.
20.01 1.30 14.29 35.48 116.42 213.29 364.16
Market Price (%) Market price return represents changes to the fund’s closing market price on its primary exchange and accounts for distributions from the fund. 20.99 1.93 16.10 39.69 123.37 256.65 353.36
  2012 2013 2014 2015 2016
Total Return (%) Total return represents changes to the NAV and accounts for distributions from the fund. 17.70 36.22 24.86 10.70 -5.31
Market Price (%) Market price return represents changes to the fund’s closing market price on its primary exchange and accounts for distributions from the fund. 21.30 40.04 33.69 8.87 -11.71

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.


Returns are shown net of advisory fees paid by the fund and net of the fund’s operating fees and expenses. Investors who purchase shares of the fund through an investment adviser or other financial professional may separately pay a fee to that service provider. Past performance is not indicative of future results.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart

Key Facts

Key Facts

Net Assets as of Dec 14, 2017 $331,060,227
Managed Assets as of Dec 14, 2017 $331,060,227.40
Share Class launch date Mar 31, 2005
Exchange New York Stock Exchange Inc.
Asset Class Equity
Morningstar Category Health
Lipper Classification Sector Equity Funds
CUSIP 09250W107
Management Fee 1.00%
Gross Expense Ratio 1.14%
Shares Outstanding as of Dec 14, 2017 9,286,502
Number of Holdings as of Nov 30, 2017 103
3m Avg Volume as of Aug 24, 2017 20,980.00

Ratings

Ratings

Holdings

Holdings

as of Nov 30, 2017
Name Weight (%)
UNITEDHEALTH GROUP INC 8.45
MEDTRONIC PLC 3.94
PFIZER INC 3.89
STRYKER CORPORATION 3.41
ABBOTT LABORATORIES 3.25
Name Weight (%)
AMGEN INC 3.06
CIGNA CORPORATION 2.91
JOHNSON & JOHNSON 2.65
AETNA INC 2.38
BAXTER INTERNATIONAL INC 2.37

Exposure Breakdowns

Exposure Breakdowns

as of Nov 30, 2017

% of Market Value Based on Managed Assets

Type Fund
as of Nov 30, 2017

% of Market Value Based on Managed Assets

Type Fund
as of Nov 30, 2017

% of Market Value Based on Managed Assets

Type Fund
as of Nov 30, 2017

% of Market Value Based on Managed Assets

Type Fund
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team

  

Kyle McClements
Kyle McClements
Christopher Accettella
Christopher Accettella
Portfolio Manager

Literature

Literature